Finance

Lists
Why is AGL up 4.85%?
Dive Deeper
AGL:NYSE
Agilon Health Inc
$115.66
+4.85%
(+5.36) 1D
$115.66
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGL...
Open
$111.98
High
$116.50
Low
$107.18
Mkt. cap
1.94B
Avg. vol.
209.95K
Volume
152.54K
52-wk high
$133.04
52-wk low
$7.48
EPS
-$5.44
Beta
3.10
Shares outstanding
16.80M
No. of employees
856
Open
$111.98
High
$116.50
Low
$107.18
Mkt. cap
1.94B
Avg. vol.
209.95K
Volume
152.54K
52-wk high
$133.04
52-wk low
$7.48
EPS
-$5.44
Beta
3.10
Shares outstanding
16.80M
No. of employees
856
News stories
From web sources and news partners
About Agilon Health Inc
CEOSteven Sell
Employees856
Founded2016
HeadquartersWesterville, Ohio, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to AGL in the past 3 months
Hold
Buy
2
Hold
4
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AGL in the last 3 months.
Highest
Current $115.66
$170.00 (+46.98%)
Average
$117.67 (+1.74%)
Lowest
$85.00 (-26.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stephen Baxter
Wells Fargo
Buy
Reiterated
$170.00
+47%
11/12/2026
Gary Taylor
TD Cowen
Hold
Maintained
$110.00
-4.9%
11/06/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$105.00
-9.2%
11/05/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$111.00
-4%
11/05/2026
Lance Wilkes
Bernstein
Buy
Maintained
$125.00
+8.1%
11/04/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/28/2026
Lisa Gill
J.P. Morgan
Sell
Maintained
$85.00
-26.5%
08/24/2026
Daniel Grosslight
Citi
Hold
Upgraded
$115.00
-0.6%
08/11/2026
Ryan Langston
TD Cowen
Hold
Maintained
$95.00
-17.9%
08/07/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$116.00
+0.3%
08/06/2026
Bill Sutherland
StoneX
Buy
Maintained
$140.00
+21%
08/06/2026
Matthew Shea
Needham
Hold
Reiterated
-
-
08/06/2026
Ryan Daniels
William Blair
Hold
Maintained
-
-
08/05/2026
Jack Slevin
Jefferies
Buy
Upgraded
$48.00
-58.5%
05/07/2026
George Hill
Deutsche Bank
Buy
Upgraded
$49.00
-57.6%
05/07/2026
Michael Craig Jones
Bank of America Securities
Sell
Reiterated
$22.00
-81%
05/07/2026
Gordon Ramsay CFA
RBC Capital
Buy
Maintained
-
-
02/08/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$2.08 / -$0.73
+384.81%beat
Revenue / Est. (USD)
1.52B / 1.47B
+3.62%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.57B
1.42B
1.49B
1.52B
Cost of goods sold
1.66B
1.36B
1.39B
1.42B
Cost of revenue
1.66B
1.36B
1.39B
1.42B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.76M
48.12M
80.87M
63.95M
Operating expense
65.73M
54.90M
87.73M
70.69M
Total operating expenses
1.73B
1.41B
1.48B
1.49B
Operating income
-156.40M
10.11M
19.41M
27.29M
Other non operating income
38.04M
13.22M
12.52M
15.32M
EBT including unusual items
-187.56M
29.94M
17.58M
38.91M
EBT excluding unusual items
-150.13M
36.06M
25.22M
42.09M
Income tax expense
1.32M
28.00K
-375.00K
4.00M
Effective tax rate
-0.71%
0.09%
-2.13%
10.27%
Other operating expenses
-
-
-
-
Net income
-188.88M
48.92M
17.96M
34.91M
Net profit margin
-12.03%
3.44%
1.20%
2.30%
Earnings per share
-8.95
2.32
2.15
2.08
Interest and investment income
3.00M
2.80M
2.50M
2.20M
Interest expense
-1.72M
-1.81M
-1.61M
-1.74M
Net interest expenses
1.28M
989.00K
892.00K
456.00K
Depreciation and amortization charges
6.97M
6.79M
6.86M
6.74M
EBITDA
-152.68M
16.90M
26.27M
34.03M
Gain or loss from assets sale
-14.00M
-
-19.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps